JP2016030748A - Hair restoration and scalp improving agent by oral administration - Google Patents
Hair restoration and scalp improving agent by oral administration Download PDFInfo
- Publication number
- JP2016030748A JP2016030748A JP2014155105A JP2014155105A JP2016030748A JP 2016030748 A JP2016030748 A JP 2016030748A JP 2014155105 A JP2014155105 A JP 2014155105A JP 2014155105 A JP2014155105 A JP 2014155105A JP 2016030748 A JP2016030748 A JP 2016030748A
- Authority
- JP
- Japan
- Prior art keywords
- scalp
- hair
- improving agent
- hair growth
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004761 scalp Anatomy 0.000 title claims abstract description 117
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 88
- 239000000284 extract Substances 0.000 claims abstract description 35
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229930003802 tocotrienol Natural products 0.000 claims abstract description 18
- 239000011731 tocotrienol Substances 0.000 claims abstract description 18
- 235000019148 tocotrienols Nutrition 0.000 claims abstract description 18
- 239000012528 membrane Substances 0.000 claims abstract description 17
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 15
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 15
- 208000001840 Dandruff Diseases 0.000 claims abstract description 12
- 206010061218 Inflammation Diseases 0.000 claims abstract description 10
- 230000004054 inflammatory process Effects 0.000 claims abstract description 10
- 230000002611 ovarian Effects 0.000 claims abstract description 10
- 230000003779 hair growth Effects 0.000 claims description 97
- 235000011430 Malus pumila Nutrition 0.000 claims description 16
- 235000015103 Malus silvestris Nutrition 0.000 claims description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 10
- 235000021388 linseed oil Nutrition 0.000 claims description 9
- 239000000944 linseed oil Substances 0.000 claims description 9
- 239000003921 oil Substances 0.000 claims description 9
- 235000019198 oils Nutrition 0.000 claims description 9
- 244000105624 Arachis hypogaea Species 0.000 claims description 8
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 8
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 7
- 235000018262 Arachis monticola Nutrition 0.000 claims description 7
- 240000007594 Oryza sativa Species 0.000 claims description 7
- 235000007164 Oryza sativa Nutrition 0.000 claims description 7
- 235000020232 peanut Nutrition 0.000 claims description 7
- 235000009566 rice Nutrition 0.000 claims description 7
- 241001629703 Pueraria candollei var. mirifica Species 0.000 claims description 6
- 229940002508 ginger extract Drugs 0.000 claims description 6
- 235000020708 ginger extract Nutrition 0.000 claims description 6
- 230000001629 suppression Effects 0.000 claims description 6
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims description 5
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 5
- 229930195722 L-methionine Natural products 0.000 claims description 5
- 229960004452 methionine Drugs 0.000 claims description 5
- 239000010018 saw palmetto extract Substances 0.000 claims description 5
- 229940063845 saw palmetto extract Drugs 0.000 claims description 5
- 229960000984 tocofersolan Drugs 0.000 claims description 5
- 239000002076 α-tocopherol Substances 0.000 claims description 5
- 235000004835 α-tocopherol Nutrition 0.000 claims description 5
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 4
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 4
- 235000021283 resveratrol Nutrition 0.000 claims description 4
- 229940016667 resveratrol Drugs 0.000 claims description 4
- 240000001548 Camellia japonica Species 0.000 claims description 3
- 244000070406 Malus silvestris Species 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 239000010495 camellia oil Substances 0.000 claims description 3
- 235000018597 common camellia Nutrition 0.000 claims description 3
- 235000020712 soy bean extract Nutrition 0.000 claims description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 2
- 240000006365 Vitis vinifera Species 0.000 claims description 2
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 2
- 230000003813 thin hair Effects 0.000 abstract description 13
- 208000010201 Exanthema Diseases 0.000 abstract description 4
- 201000005884 exanthem Diseases 0.000 abstract description 4
- 206010037844 rash Diseases 0.000 abstract description 4
- 241000972773 Aulopiformes Species 0.000 abstract description 3
- 230000005764 inhibitory process Effects 0.000 abstract 2
- 241000220225 Malus Species 0.000 description 13
- 239000000047 product Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 8
- 210000001672 ovary Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 241001133760 Acoelorraphe Species 0.000 description 5
- 210000003128 head Anatomy 0.000 description 5
- 201000004384 Alopecia Diseases 0.000 description 4
- 241000255925 Diptera Species 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000003676 hair loss Effects 0.000 description 4
- 239000011732 tocopherol Substances 0.000 description 4
- 229960001295 tocopherol Drugs 0.000 description 4
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 3
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 229940106189 ceramide Drugs 0.000 description 3
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 208000024963 hair loss Diseases 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- OTXNTMVVOOBZCV-UHFFFAOYSA-N 2R-gamma-tocotrienol Natural products OC1=C(C)C(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 OTXNTMVVOOBZCV-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000004129 EU approved improving agent Substances 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 238000001793 Wilcoxon signed-rank test Methods 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- RZFHLOLGZPDCHJ-DLQZEEBKSA-N alpha-Tocotrienol Natural products Oc1c(C)c(C)c2O[C@@](CC/C=C(/CC/C=C(\CC/C=C(\C)/C)/C)\C)(C)CCc2c1C RZFHLOLGZPDCHJ-DLQZEEBKSA-N 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 229940038487 grape extract Drugs 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- FGYKUFVNYVMTAM-UHFFFAOYSA-N (R)-2,5,8-trimethyl-2-(4,8,12-trimethyl-trideca-3t,7t,11-trienyl)-chroman-6-ol Natural products OC1=CC(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1C FGYKUFVNYVMTAM-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- ODADKLYLWWCHNB-UHFFFAOYSA-N 2R-delta-tocotrienol Natural products OC1=CC(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 ODADKLYLWWCHNB-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 244000081841 Malus domestica Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000277269 Oncorhynchus masou Species 0.000 description 1
- 241000277275 Oncorhynchus mykiss Species 0.000 description 1
- 241000277277 Oncorhynchus nerka Species 0.000 description 1
- 241001280377 Oncorhynchus tshawytscha Species 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- 240000006661 Serenoa repens Species 0.000 description 1
- 235000005318 Serenoa repens Nutrition 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229940064063 alpha tocotrienol Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- FGYKUFVNYVMTAM-YMCDKREISA-N beta-Tocotrienol Natural products Oc1c(C)c2c(c(C)c1)O[C@@](CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)(C)CC2 FGYKUFVNYVMTAM-YMCDKREISA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- BTNBMQIHCRIGOU-UHFFFAOYSA-N delta-tocotrienol Natural products CC(=CCCC(=CCCC(=CCCOC1(C)CCc2cc(O)cc(C)c2O1)C)C)C BTNBMQIHCRIGOU-UHFFFAOYSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- FGYKUFVNYVMTAM-MUUNZHRXSA-N epsilon-Tocopherol Natural products OC1=CC(C)=C2O[C@@](CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1C FGYKUFVNYVMTAM-MUUNZHRXSA-N 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- OTXNTMVVOOBZCV-YMCDKREISA-N gamma-Tocotrienol Natural products Oc1c(C)c(C)c2O[C@@](CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)(C)CCc2c1 OTXNTMVVOOBZCV-YMCDKREISA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 231100000508 hormonal effect Toxicity 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- -1 plants Natural products 0.000 description 1
- 125000004402 polyphenol group Chemical group 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
- RZFHLOLGZPDCHJ-XZXLULOTSA-N α-Tocotrienol Chemical compound OC1=C(C)C(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1C RZFHLOLGZPDCHJ-XZXLULOTSA-N 0.000 description 1
- 235000019145 α-tocotrienol Nutrition 0.000 description 1
- 239000011730 α-tocotrienol Substances 0.000 description 1
- 235000019151 β-tocotrienol Nutrition 0.000 description 1
- 239000011723 β-tocotrienol Substances 0.000 description 1
- FGYKUFVNYVMTAM-WAZJVIJMSA-N β-tocotrienol Chemical compound OC1=CC(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1C FGYKUFVNYVMTAM-WAZJVIJMSA-N 0.000 description 1
- 235000019150 γ-tocotrienol Nutrition 0.000 description 1
- 239000011722 γ-tocotrienol Substances 0.000 description 1
- OTXNTMVVOOBZCV-WAZJVIJMSA-N γ-tocotrienol Chemical compound OC1=C(C)C(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 OTXNTMVVOOBZCV-WAZJVIJMSA-N 0.000 description 1
- 235000019144 δ-tocotrienol Nutrition 0.000 description 1
- 239000011729 δ-tocotrienol Substances 0.000 description 1
- ODADKLYLWWCHNB-LDYBVBFYSA-N δ-tocotrienol Chemical compound OC1=CC(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 ODADKLYLWWCHNB-LDYBVBFYSA-N 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
本発明は、経口投与される育毛および頭皮改善剤に関し、特に、口から摂取することにより、その優れた育毛作用により頭髪が薄くなること(薄毛)を抑制できるとともに、頭皮の炎症(かぶれ)抑制やフケの発生抑制などの頭皮改善作用を示す育毛および頭皮改善剤に関する。 The present invention relates to an orally administered hair growth and scalp improving agent, and in particular, when taken from the mouth, it is possible to suppress thinning of the hair (thin hair) due to its excellent hair growth action, and to suppress inflammation (rash) of the scalp. The present invention relates to a hair-growth and scalp-improving agent exhibiting scalp-improving action such as suppression of occurrence of dandruff and dandruff.
頭髪はその人の容姿に大きな影響を与える要因の1つであり、外見的印象を左右するという点で非常に重要である。
頭髪の薄毛は、毛が細くなったり、本数が減ったりして進行していき、さらに症状が進むと頭髪に覆われている部分が減って地肌(頭皮)が露出し、目立つようになる。
Hair is one of the factors that have a great influence on the person's appearance, and is very important in that it affects the appearance.
The thin hair of the hair progresses as the hair becomes thinner or the number of hair decreases, and when the symptom progresses, the portion covered with the hair decreases and the background (scalp) is exposed and becomes conspicuous.
薄毛が進行する原因としては、ホルモンの影響、遺伝的要素、食生活、睡眠時間の不足、ストレスなどが考えられている。
例えば従来から注目されている男性の薄毛については、男性ホルモン(テストステロン等)の影響によるものがよく知られており、典型的には前頭部や頭頂部を中心に薄毛が進行していく。
また、近年は女性における薄毛の問題にも注目が集まっている。女性の場合、例えば女性ホルモン(エストロゲン等)の分泌量の減少などが原因となって毛が細くなったり、コシが失われるなどしながら薄毛が進行していき、髪の毛全体のボリュームがなくなったり、ヘアスタイルが決まりにくくなったりすることがその症状として現れる。
Possible causes of thinning hair include hormonal effects, genetic factors, diet, lack of sleep time, and stress.
For example, male thin hair that has been attracting attention in the past is well known to be due to the effects of male hormones (testosterone, etc.), and typically thin hair progresses mainly in the frontal region and the top of the head.
In recent years, attention has been focused on the problem of thinning hair in women. In the case of women, for example, due to a decrease in the secretion of female hormones (estrogens, etc.), thinning of the hair, loss of elasticity, thinning of the hair progresses, and the overall volume of the hair disappears, The symptom is that the hairstyle is difficult to determine.
薄毛の症状が進んだ人は、髪の毛が失われる以前の自分の容姿との違いから、大きなストレスを受けることがある。近年はこのような薄毛に悩む人が増加する傾向にあり、その改善が求められている。
そのため、頭髪を維持または増やすための、種々の育毛剤が知られている(例えば特許文献1〜3)。
People with advanced thinning symptoms may experience significant stress due to differences from their appearance prior to loss of hair. In recent years, the number of people who suffer from such thinnings tends to increase, and the improvement is demanded.
Therefore, various hair growth agents for maintaining or increasing hair are known (for example,
ところで、頭髪の薄毛の進行とともに、頭皮の炎症やフケの増加などの頭皮の状態悪化が起こることがある。これらは頭髪の成長に影響を与え、薄毛をさらに悪化させる原因ともなり得る。
また、例えばフケが衣服に多量に付着しているなどすると、薄毛と同等、またはそれ以上に他人への印象に対して悪影響を与えることもある。
そのため、薄毛の進行を抑え頭髪を維持または増やすことと併せて、頭皮状態も改善できることが好ましい。
By the way, with the progress of thinning hair of the scalp, the scalp condition may worsen such as inflammation of the scalp and increased dandruff. These affect hair growth and can cause further deterioration of thinning hair.
In addition, for example, if a large amount of dandruff adheres to clothes, it may have an adverse effect on the impression to others as much as or more than thin hair.
Therefore, it is preferable that the scalp state can be improved in combination with suppressing the progress of thinning hair and maintaining or increasing the hair.
また、育毛剤は従来、液体状に調製され、頭部に直接塗布して使用する態様のものが一般的であったが、投与時において他人から注目を集めやすい点なども考慮すると、より手軽に使用できるものが好ましい。 In addition, hair growth agents are conventionally prepared in a liquid form and generally used in a form that is applied directly to the head, but it is easier to take into account the points that attract attention from others at the time of administration. Those that can be used in the above are preferred.
本発明はこのような事情に基づきなされたものであり、経口投与により、頭髪を維持または増やすことができるとともに、頭皮状態を改善可能である育毛および頭皮改善剤を提供することを目的とする。 This invention is made | formed based on such a situation, and it aims at providing the hair growth and scalp improving agent which can improve a scalp state while being able to maintain or increase a head hair by oral administration.
すなわち、本発明の要旨は以下のとおりである。
[1] リンゴポリフェノール、トコトリエノールおよび鮭類の卵巣膜抽出物を含有することを特徴とする経口で投与される育毛および頭皮改善剤。
[2] 前記リンゴポリフェノールが前記育毛および頭皮改善剤あたり1質量%以上40質量%以下含有されることを特徴とする[1]に記載の育毛および頭皮改善剤。
[3] 前記トコトリエノールが前記育毛および頭皮改善剤あたり0.5質量%以上40質量%以下含有されることを特徴とする[1]または[2]に記載の育毛および頭皮改善剤。
[4] 前記鮭類の卵巣膜抽出物が前記育毛および頭皮改善剤あたり1質量%以上25質量%以下含有されることを特徴とする[1]から[3]のいずれか1つに記載の育毛および頭皮改善剤。
[5] 頭皮の改善作用として頭皮の炎症抑制またはフケの発生抑制を示すことを特徴とする[1]から[4]のいずれか1つに記載の育毛および頭皮改善剤。
[6] 前記育毛および頭皮改善剤が女性用の育毛および頭皮改善剤であり、
亜麻仁油、ショウガエキス、d-α-トコフェロール、プエラリアミリフィカ粉末、L−メチオニンおよびラッカセイ種皮抽出物をさらに含有することを特徴とする[1]から[5]のいずれか1つに記載の育毛および頭皮改善剤。
[7] 前記育毛および頭皮改善剤が男性用の育毛および頭皮改善剤であり、
ノコギリヤシ抽出物および米胚芽油をさらに含有することを特徴とする[1]から[5]のいずれか1つに記載の育毛および頭皮改善剤。
[8] 大豆抽出物、レスベラトロール含有ブドウ抽出物、ツバキ種子抽出物、酒酵母、ツバキ油、生物ミネラルおよびパインセラミドのうち少なくとも1つをさらに含有することを特徴とする[1]から[7]のいずれか1つに記載の育毛および頭皮改善剤。
That is, the gist of the present invention is as follows.
[1] An orally administered hair-growth and scalp improving agent characterized by containing ovarian membrane extract of apple polyphenol, tocotrienol and moss.
[2] The hair-growth and scalp improving agent according to [1], wherein the apple polyphenol is contained in an amount of 1% by mass to 40% by mass based on the hair-growth and scalp improving agent.
[3] The hair growth and scalp improving agent according to [1] or [2], wherein the tocotrienol is contained in an amount of 0.5% by mass to 40% by mass with respect to the hair restoring and scalp improving agent.
[4] The ovarian membrane extract of the moss is contained in an amount of 1% by mass to 25% by mass per the hair growth and scalp improving agent, according to any one of [1] to [3] Hair growth and scalp improving agent.
[5] The hair-growth and scalp improving agent according to any one of [1] to [4], wherein the scalp ameliorating action is suppression of scalp inflammation or dandruff.
[6] The hair growth and scalp improving agent is a hair growth and scalp improving agent for women,
The hair growth according to any one of [1] to [5], further comprising flaxseed oil, ginger extract, d-α-tocopherol, pueraria mirifica powder, L-methionine and peanut seed coat extract Scalp improving agent.
[7] The hair growth and scalp improving agent is a male hair growth and scalp improving agent,
The hair-growth and scalp improving agent according to any one of [1] to [5], further comprising a saw palmetto extract and rice germ oil.
[8] It further comprises at least one of soybean extract, resveratrol-containing grape extract, camellia seed extract, liquor yeast, camellia oil, biominerals and pine ceramide [1] to [1] [7] The hair growth and scalp improving agent according to any one of [7].
本発明によれば、経口投与により、頭髪を維持または増やすことができるとともに、頭皮状態を改善可能である育毛および頭皮改善剤を提供することができる。
すなわち、リンゴポリフェノール、トコトリエノールおよび鮭類の卵巣膜抽出物を含有する本発明の育毛および頭皮改善剤を服用することにより、髪の毛の成長を促進し、頭髪を維持または増やして薄毛の進行を抑制することができる。さらに、頭皮の炎症抑制、フケの発生抑制等といった頭皮改善作用により頭皮状態を改善することができる。
ADVANTAGE OF THE INVENTION According to this invention, the hair growth and scalp improving agent which can maintain or increase scalp hair and can improve a scalp state by oral administration can be provided.
That is, by taking the hair growth and scalp improving agent of the present invention containing apple polyphenol, tocotrienol and mosquito ovary membrane extract, it promotes hair growth and maintains or increases scalp to suppress the progression of thinning hair be able to. Furthermore, the scalp state can be improved by the scalp improving action such as suppression of inflammation of the scalp and generation of dandruff.
次に、本発明の育毛および頭皮改善剤の1つの実施形態について説明する。
本実施形態の育毛および頭皮改善剤は、リンゴポリフェノール、トコトリエノールおよび鮭類の卵巣膜抽出物(以下、鮭卵巣膜抽出物とも称す)を含有することを特徴としており、経口投与の形で摂取される。
Next, one embodiment of the hair growth and scalp improving agent of the present invention will be described.
The hair growth and scalp improving agent of this embodiment is characterized by containing apple polyphenol, tocotrienol, and mosquito ovary membrane extract (hereinafter also referred to as vaginal ovary membrane extract), and is taken orally. The
リンゴポリフェノールは、リンゴ(Malus pumila)の果実から抽出されたポリフェノール群(エピカテキン、カフェ酸、プロシアニジン等)であって、抗酸化作用などを有する。
ここで、リンゴポリフェノールは、育毛および頭皮状態の改善の観点から、本実施形態の育毛および頭皮改善剤あたり1質量%以上40質量%以下含有されることが好ましく、5質量%以上25質量%以下含有されることがより好ましい。
リンゴポリフェノールは、リンゴから例えば特許文献1や特許文献2に記載された方法により抽出されたものを用いることができるほか、市販品を用いるようにしてもよい。
Apple polyphenol is a polyphenol group (epicatechin, caffeic acid, procyanidin, etc.) extracted from the fruit of apple (Malus pumila), and has an antioxidant effect and the like.
Here, the apple polyphenol is preferably contained in an amount of 1% by mass or more and 40% by mass or less, preferably 5% by mass or more and 25% by mass or less, based on the hair growth and scalp improving agent of the present embodiment, from the viewpoint of hair growth and scalp condition improvement. More preferably it is contained.
As the apple polyphenol, those extracted from apples by the method described in
トコトリエノールは、ビタミンE(トコフェロール)同族体であり、トコフェロールの直鎖アルキル基に3つの不飽和結合部分を有する化合物であって、ビタミンEの数十倍程度の強い抗酸化作用を有する。また、高脂血症改善作用を有する成分としても知られている。
ここで、トコトリエノールは、育毛および頭皮状態の改善の観点から、本実施形態の育毛および頭皮改善剤あたり0.5質量%以上40質量%以下含有されることが好ましく、1質量%以上20質量%含有されることがより好ましい。
トコトリエノールは、植物等の天然物の圧搾、抽出、または合成などの方法で得ることができ、一般的にはパームヤシなどのヤシ科植物の果皮および/または種子から抽出される。本実施形態の育毛および頭皮改善剤においては、天然物由来、合成物のいずれであっても用いることができる。また、α−トコトリエノール、β−トコトリエノール、γ−トコトリエノール、δ−トコトリエノールのいずれを使用することも可能であり、これらを組み合わせて使用してもよい。また、天然物由来の場合、精製されたもののほか、植物抽出物(例えばパームヤシエキス)などを、トコトリエノール供給源として、本実施形態に配合することもできる。
Tocotrienol is a vitamin E (tocopherol) homologue, a compound having three unsaturated bonds in the linear alkyl group of tocopherol, and has a strong antioxidative effect about several tens of times that of vitamin E. It is also known as a component having an action for improving hyperlipidemia.
Here, it is preferable that tocotrienol is contained in an amount of 0.5% by mass or more and 40% by mass or less, preferably 1% by mass or more and 20% by mass or less, based on the hair growth and scalp improving agent of the present embodiment from the viewpoint of hair growth and scalp condition. More preferably it is contained.
Tocotrienol can be obtained by a method such as pressing, extraction, or synthesis of natural products such as plants, and is generally extracted from the skin and / or seeds of palm plant such as palm palm. The hair growth and scalp improving agent of the present embodiment can be used from any natural product or synthetic product. Any of α-tocotrienol, β-tocotrienol, γ-tocotrienol, and δ-tocotrienol can be used, and these may be used in combination. Moreover, in the case of being derived from a natural product, a plant extract (for example, palm palm extract) or the like can be blended in the present embodiment as a tocotrienol supply source in addition to a purified product.
鮭類の卵巣膜抽出物は、鮭類の卵巣膜から得られる抽出物である。なお、本明細書において、鮭類とは、分類上のサケ科である生物を意味しており、具体的にはサケ、紅ザケ、銀ザケ、ニジマス、サクラマス、マスノスケ等を挙げることができる。
ここで、鮭類の卵巣膜抽出物は、本実施形態の育毛および頭皮改善剤あたり1質量%以上25質量%以下含有されることが好ましく、2質量%以上12質量%以下含有されることがより好ましい。
鮭類の卵巣膜抽出物は、例えば特開2011−026273号公報に記載された方法により抽出されたものを用いることができるほか、市販品を利用することもできる。
The mosquito ovarian membrane extract is an extract obtained from the mosquito ovarian membrane. In addition, in this specification, moss means the organism which is a salmonid department on classification, and can specifically mention salmon, red salmon, silver salmon, rainbow trout, cherry salmon, chinook salmon, and the like.
Here, the ovarian membrane extract of moss is preferably contained in an amount of 1% by mass or more and 25% by mass or less, preferably 2% by mass or more and 12% by mass or less, per the hair growth and scalp improving agent of the present embodiment. More preferred.
As the ovarian membrane extract of moss, for example, those extracted by the method described in JP 2011-026273 A can be used, and commercially available products can also be used.
また、本実施形態の育毛および頭皮改善剤は、これらリンゴポリフェノール、トコトリエノール、および鮭卵巣膜抽出物に加えて他の成分を含有するようにしてもよい。
例えば、本実施形態の育毛および頭皮改善剤を、女性用の育毛および頭皮改善剤とする場合、当該育毛および頭皮改善剤は、リンゴポリフェノールおよびトコトリエノールおよび鮭卵巣膜抽出物に加えて、亜麻仁油、ショウガエキス、d-α-トコフェロール、プエラリアミリフィカ粉末、L-メチオニンおよびラッカセイ種皮抽出物をさらに含有することが好ましい。当該成分を含有することにより、女性における育毛作用をさらに高めることができる。
Moreover, the hair growth and scalp improving agent of this embodiment may contain other components in addition to these apple polyphenols, tocotrienol, and rabbit ovary membrane extract.
For example, when the hair growth and scalp improving agent of this embodiment is used as a female hair growth and scalp improving agent, the hair growth and scalp improving agent is added to apple polyphenol and tocotrienol and vaginal ovary membrane extract, linseed oil, It is preferable to further contain ginger extract, d-α-tocopherol, Pueraria mirifica powder, L-methionine and peanut seed coat extract. By containing the said component, the hair-restoration effect | action in a woman can further be improved.
亜麻仁油は、アマ(Linum usitatissimum)の種子から取られるオイル(精油)である。亜麻仁油は例えば市販品を用いるようにしてもよい。
ショウガエキスは、ショウガ(Zingiber officinale)の根茎から二酸化炭素等で抽出される、油状抽出物である。当該ショウガエキスは、亜麻仁油同様に市販品を用いるようにしてもよい。
d-α-トコフェロールは、ビタミンEの1種であり、例えば市販品を用いるようにしてもよい。また、当該d-α-トコフェロールを含む植物油などを配合する態様とすることもできる。
プエラリアミリフィカ粉末は、東南アジアに生育する植物であるプエラリアミリフィカ(Pueraria mirifica)の粉末である。当該粉末は、亜麻仁油などと同様に市販品を用いてもよい。
L−メチオニンはアミノ酸の一種であり、例えば市販品を用いることができる。
ラッカセイ種皮抽出物(ラッカセイ種皮エキス)は、ラッカセイ(Arachis hypogaea)の果実の薄皮(種皮)の抽出物である。当該抽出物は、例えば特開平11−246562号公報に記載された方法により得ることができるほか、亜麻仁油などと同様に市販品を用いてもよい。
Linseed oil is an oil (essential oil) taken from the seeds of flax (Linum usitatissimum). For example, a commercially available linseed oil may be used.
The ginger extract is an oily extract extracted from the rhizome of ginger (Zingiber officinale) with carbon dioxide or the like. As the ginger extract, a commercially available product may be used in the same manner as linseed oil.
d-α-tocopherol is a kind of vitamin E, and for example, a commercially available product may be used. Moreover, it can also be set as the aspect which mix | blends the vegetable oil containing the said d- (alpha) -tocopherol.
Pueraria mirifica powder is a powder of Pueraria mirifica, a plant that grows in Southeast Asia. As the powder, a commercially available product may be used in the same manner as linseed oil.
L-methionine is a kind of amino acid, and for example, a commercially available product can be used.
Peanut seed coat extract (Peanut seed coat extract) is an extract of peanut (Arachis hypogaea) fruit skin (seed coat). The extract can be obtained by, for example, the method described in JP-A No. 11-246562, and a commercially available product may be used in the same manner as linseed oil.
ここで、亜麻仁油は、15質量%以上60質量%以下含有されるようにすることが好ましい。また、同様に、ショウガエキスは、1質量%以上10質量%以下含有されるようにすることが好ましい。d-α-トコフェロールは、0.5質量%以上20質量%以下含有されるようにすることが好ましい。プエラリアミリフィカ粉末は、2質量%以上40質量%以下含有されるようにすることが好ましい。また、L−メチオニンは、0.1質量%以上10質量%以下含有されるようにすることが好ましい。また、ラッカセイ種皮抽出物は、1質量%以上10質量%以下含有されるようにすることが好ましい。(いずれも本実施形態の育毛および頭皮改善剤あたり) Here, the linseed oil is preferably contained in an amount of 15% by mass to 60% by mass. Similarly, the ginger extract is preferably contained in an amount of 1% by mass to 10% by mass. It is preferable that d-α-tocopherol is contained in an amount of 0.5% by mass or more and 20% by mass or less. The Pueraria mirifica powder is preferably contained in an amount of 2 to 40% by mass. Further, L-methionine is preferably contained in an amount of 0.1% by mass or more and 10% by mass or less. The peanut seed coat extract is preferably contained in an amount of 1% by mass to 10% by mass. (Every hair growth and scalp improving agent of this embodiment)
また、本実施形態の育毛および頭皮改善剤を、男性用の育毛および頭皮改善剤とすることもできる。男性用の育毛および頭皮改善剤とする場合、当該育毛および頭皮改善剤は、リンゴポリフェノール、トコトリエノールおよび鮭卵巣膜抽出物に加えて、ノコギリヤシ抽出物および米胚芽油をさらに含有することが好ましい。当該成分を含有することにより、男性における育毛作用をさらに高めることができる。また、毛穴の詰まり、頭皮のべたつきを抑えることもできる。 Moreover, the hair growth and scalp improving agent of this embodiment can also be used as the male hair growth and scalp improving agent. In the case of a male hair-growth and scalp improving agent, the hair-growth and scalp improving agent preferably further contains a saw palmetto extract and rice germ oil in addition to apple polyphenol, tocotrienol and rabbit ovary membrane extract. By containing the said component, the hair-restoration effect | action in a male can further be improved. In addition, clogging of pores and stickiness of the scalp can be suppressed.
ノコギリヤシ抽出物(ノコギリヤシエキス)は、ノコギリヤシ(Serenoa repens)の果実の抽出物である。当該抽出物は、例えば特開2007−063204号公報に記載された方法により得ることができるほか、市販品を用いてもよい。
米胚芽油は、米の胚芽から取られるオイルである。当該米胚芽油は、ノコギリヤシ抽出物と同様に、市販品を用いるようにしてもよい。
Saw palm extract (saw palm extract) is an extract of the fruit of Serenoa repens. The extract can be obtained by, for example, a method described in JP-A-2007-063204, or a commercially available product may be used.
Rice germ oil is oil taken from rice germ. As the rice germ oil, a commercially available product may be used in the same manner as the saw palmetto extract.
ここで、ノコギリヤシ抽出物は、本実施形態の育毛および頭皮改善剤あたり5質量%以上50質量%以下含有されるようにすることが好ましい。また、同様に、米胚芽油は、本実施形態の育毛および頭皮改善剤あたり5質量%以上40質量%以下含有されるようにすることが好ましい。 Here, the saw palmetto extract is preferably contained in an amount of 5% by mass or more and 50% by mass or less per hair growth and scalp improving agent of the present embodiment. Similarly, the rice germ oil is preferably contained in an amount of 5% by mass or more and 40% by mass or less per hair growth and scalp improving agent of the present embodiment.
さらに、本実施形態においては育毛作用等に寄与する他の成分を含むようにすることができる。
育毛作用等に寄与する成分として、具体的には、大豆抽出物、レスベラトロール含有ブドウ抽出物(ブドウレスベラトロール粉末)、ツバキ種子抽出物、酒酵母、ツバキ油、植物等から抽出されたミネラル分である生物ミネラル、パインセラミド(パイナップル果実(可食部分)由来の植物性セラミド)などを挙げることができ、例えば、本実施形態においては、これらを1種または2種以上含有するようにすることができる。さらにまた、例えば男性用の育毛および頭皮改善剤にトコフェロールが含まれるようにすることもできる。
Furthermore, in this embodiment, it can be made to contain the other component which contributes to the hair restoring action etc.
Specifically, it is extracted from soybean extract, resveratrol-containing grape extract (grape resveratrol powder), camellia seed extract, liquor yeast, camellia oil, plants, etc. Biological minerals that are minerals, pine ceramide (plant ceramide derived from pineapple fruit (edible part)), and the like can be mentioned. For example, in the present embodiment, one or more of these are contained. can do. Furthermore, for example, tocopherol may be included in a hair growth and scalp improving agent for men.
さらに、本実施形態においては、育毛および頭皮改善剤全体で100質量%とする量の担体や基剤等の他の成分を含むようにすることができる。
担体は、本実施形態において含有される各成分を溶解または分散させて保持する。担体は特に限定されないが、胃腸経路からの各成分の吸収を助けるものであるのが好ましい。適当な担体の例は、食用油(例えばオリーブ油)、動物産物に基づく担体(例えばゼラチン)、アラビアガム、スクロース、脂質、モノおよびジグリセリド、ならびにマルトデキストリンである。また、水も担体として使用することができるが、通常、適当な乳化剤(例えば、レシチン、ソルビタン モノラウレート)とともに使用される。
なお、各成分の混合方法は、各成分ができるだけ均一に分散するように混合すればよく、特に限定されない。また、担体のほか、硬度調整剤や吸収改良剤を含むようにしてもよい。
基剤についても、当業者が適宜設定でき、特に限定されない。
Furthermore, in this embodiment, it can be made to contain other components, such as a carrier and a base of the quantity made into 100 mass% with respect to the hair growth and scalp improving agent whole.
The carrier holds each component contained in the present embodiment dissolved or dispersed. The carrier is not particularly limited, but is preferably one that assists absorption of each component from the gastrointestinal route. Examples of suitable carriers are edible oils (eg olive oil), animal product based carriers (eg gelatin), gum arabic, sucrose, lipids, mono and diglycerides, and maltodextrins. Water can also be used as a carrier, but is usually used together with a suitable emulsifier (for example, lecithin, sorbitan monolaurate).
In addition, the mixing method of each component should just mix so that each component may disperse | distribute as uniformly as possible, and is not specifically limited. In addition to the carrier, a hardness adjusting agent or an absorption improving agent may be included.
The base can be appropriately set by those skilled in the art and is not particularly limited.
本実施形態の育毛および頭皮改善剤は、例えば、溶液、オイル、エマルジョン、懸濁液または分散液の形態を有する医薬品、医薬部外品または食品などとして、経口投与することができる。適当な形態は、例えば、カプセルまたは錠剤である。本実施形態の育毛および頭皮改善剤は、通常、軟ゼラチンカプセルの形態で提供される。
本実施形態の育毛および頭皮改善剤が服用される量は、特に限定されず、担体の剤型などを考慮して適宜設定可能であるが、例えば軟ゼラチンカプセル1日あたりにおいてリンゴポリフェノール100〜150mg、トコトリエノール10〜150mgおよび鮭卵巣膜抽出物25〜100mgが経口投与されるような量に設定することができる。
The hair growth and scalp improving agent of this embodiment can be orally administered, for example, as a pharmaceutical, a quasi-drug or a food having the form of a solution, oil, emulsion, suspension or dispersion. Suitable forms are, for example, capsules or tablets. The hair growth and scalp improving agents of this embodiment are usually provided in the form of soft gelatin capsules.
The amount taken of the hair growth and scalp improving agent of the present embodiment is not particularly limited and can be appropriately set in consideration of the dosage form of the carrier. For example, apple polyphenol 100 to 150 mg per soft gelatin capsule per day , 10 to 150 mg of tocotrienol and 25 to 100 mg of vaginal ovarian membrane extract can be set to such an amount as to be administered orally.
以上、本実施形態によれば、個人差はあるが、経口投与により、頭髪を維持または増やすことができるとともに、頭皮状態を改善可能である育毛および頭皮改善剤を提供することができる。
リンゴポリフェノール、トコトリエノール、および鮭卵巣膜抽出物を含有する本実施形態の育毛および頭皮改善剤を服用することにより、髪の毛の成長を促進し、頭髪を維持または増やして薄毛の進行を抑制することができる。さらに、頭皮の炎症抑制、フケの発生抑制といった頭皮改善作用により頭皮状態を改善することができる。
As described above, according to this embodiment, although there are individual differences, it is possible to provide a hair-growth and scalp improving agent capable of maintaining or increasing the hair by oral administration and improving the scalp state.
By taking the hair-growth and scalp improving agent of this embodiment containing apple polyphenol, tocotrienol, and rabbit ovary membrane extract, it can promote hair growth and maintain or increase hair and suppress the progression of thin hair it can. Furthermore, the scalp state can be improved by the scalp improving action such as suppression of scalp inflammation and dandruff.
さらに本実施形態の育毛および頭皮改善剤は、優れた育毛効果を有しており、育毛作用が知られる他の成分を個別に服用する場合と比較して、より高い育毛効果を示す。 Furthermore, the hair-growth and scalp improving agent of the present embodiment has an excellent hair-growth effect, and exhibits a higher hair-growth effect as compared to the case where other ingredients with known hair-growth action are individually taken.
さらに本実施形態の育毛および頭皮改善剤は、経口投与の態様で摂取されるため、頭部に直接投与される従来の育毛剤などと比較して、より手軽に使用することができる。そのため、例えば旅行先などに携行し、他人の視線を気にすることなく使用することも可能である。 Furthermore, since the hair-growth and scalp improving agent of this embodiment is ingested by oral administration, it can be used more easily than conventional hair-growth agents directly administered to the head. Therefore, for example, it is possible to carry it to a travel destination and use it without worrying about the eyes of others.
以下、実施例によって本発明の育毛および頭皮改善剤をより具体的に説明する。なお、本発明はこれに限定されるものではない。 Hereinafter, the hair growth and scalp improving agents of the present invention will be described more specifically by way of examples. Note that the present invention is not limited to this.
以下に示す成分を混合して本実施例の育毛および頭皮改善剤を製造した。 The following ingredients were mixed to produce the hair growth and scalp improving agent of this example.
具体的には、表1、表2にそれぞれ記載される成分を混合し、ゼラチンカプセルに充填して、男性用の育毛および頭皮改善剤を実施例1として、また、女性用の育毛および頭皮改善剤を実施例2として得た(カプセル1粒は、それぞれ470mg)。 Specifically, the ingredients described in Tables 1 and 2 are mixed and filled into gelatin capsules, and the hair growth and scalp improving agent for men is used as Example 1, and hair growth and scalp improvement for women are performed. The agent was obtained as Example 2 (one capsule was 470 mg each).
1日に3粒ずつ、実施例1の育毛および頭皮改善剤を男性(15名)に、実施例2の育毛および頭皮改善剤を女性(14名)に投与した。投与開始から16週後の頭髪の状態および頭皮状態の変化について、投与開始前と投与開始から16週後のパネラーの頭部の画像をもとに、3名の医師(皮膚科医)による判定を行った。また、育毛作用については、被験者自身による判定も行った。 The hair growth and scalp improving agent of Example 1 was administered to males (15 people) and the hair growth and scalp improving agent of Example 2 to females (14 people) three times a day. Changes in hair condition and scalp status 16 weeks after the start of administration are determined by three doctors (dermatologists) based on images of the heads of the panelists before and 16 weeks after the start of administration. Went. Moreover, about the hair-growth effect | action, the test subject's own determination was also performed.
なお、育毛についての被験者自身の判定は、以下の基準に基づき各被験者のスコアを決定した。判定の有意性はWilcoxon検定により評価を行った。
抜け毛の程度:1. 「ほとんどなし(気にならない)」、2. 「少しある(少し気になる)」、3. 「どちらともいえない」、4. 「多い(気になる)」
髪の毛のハリ、コシ:1. 「ある」、2. 「どちらかといえばある」、3. 「どちらともいえない」、4. 「どちらかといえばない」、5. 「ない」
髪の毛の色、つや:1. 「ある」、2. 「どちらかといえばある」、3. 「どちらともいえない」、4. 「どちらかといえばない」、5. 「ない」
In addition, the test subject's own judgment about hair growth determined the score of each test subject based on the following criteria. The significance of the determination was evaluated by the Wilcoxon test.
Degree of hair loss: "Nearly nothing (I don't care)", 2. “There is a little (I am a little worried),” 3. “I can't say either.” “Many (I'm interested)”
Harness and stiffness of hair: 1. “Yes”, 2. “If anything,” 3. “I can't say either.” “It ’s not good”, 5. "Absent"
Hair color, gloss: “Yes”, 2. “If anything,” 3. “I can't say either.” “It ’s not good”, 5. "Absent"
また、頭皮状態の医師による判定は、以下の基準に基づき各被験者のスコアを決定した。判定の有意性は、被験者自身の判定の場合と同様に、Wilcoxon検定により評価を行った。
0「なし:症状が認められない」、1「軽微:わずかに症状が認められる」、2「軽度:少し症状が認められる」、3「中程度:明らかな症状が認められる」、4「重度:著しい症状が認められる」
Moreover, the judgment by the doctor of the scalp state determined the score of each subject based on the following criteria. The significance of the determination was evaluated by the Wilcoxon test as in the case of the subject's own determination.
0 “None: no symptoms” 1 “Minor: slightly symptoms” 2 “Mild: slightly symptoms” 3 “Medium: obvious symptoms” 4 “Severe” : There are significant symptoms "
投与開始から16週経過後の結果を図1〜13に示す。
医師および被験者自身の判定いずれの場合も、経口投与開始前と比較して、投与から16週経過後に、個人差はあるものの、実施例1、2ともに頭髪について育毛作用があると確認できる結果が得られた。当該結果から、例えばトコトリエノールを単独で投与した場合(Lim Ai Beoy, Wong Jia Woei, Yuen Kah Hay,“Effects of Tocotrienol Supplementation on Hair Growth in Human Volunteers”, Tropical Life Sciences Research, 21(2), 91-99, 2010.)と比較し、本実施形態の育毛および頭皮改善剤が優れた育毛作用を有すると理解できる。
また、炎症およびフケの発生量についても、実施例1、2ともに、投与開始前と比較して改善が確認できた。さらに、実施例1の育毛および頭皮改善剤を男性に投与した場合に、毛穴の詰まりおよび頭皮のべたつきについても改善が見られることが確認できた。
The results after 16 weeks from the start of administration are shown in FIGS.
In both cases of doctor and subject's own judgment, there are individual differences after 16 weeks from the start of administration compared to before the start of oral administration. Obtained. From the results, for example, when tocotrienol was administered alone (Lim Ai Beoy, Wong Jia Woei, Yuen Kah Hay, “Effects of Tocotrienol Supplementation on Hair Growth in Human Volunteers”, Tropical Life Sciences Research, 21 (2), 91- 99, 2010.), it can be understood that the hair growth and scalp improving agent of this embodiment has an excellent hair growth action.
In addition, with respect to the amount of inflammation and dandruff, both Examples 1 and 2 were confirmed to be improved compared to before administration. Furthermore, when the hair-growth and scalp improving agent of Example 1 was administered to men, it was confirmed that improvements were also observed in pore clogging and scalp stickiness.
Claims (8)
亜麻仁油、ショウガエキス、d-α-トコフェロール、プエラリアミリフィカ粉末、L−メチオニンおよびラッカセイ種皮抽出物をさらに含有することを特徴とする請求項1から5のいずれか1つに記載の育毛および頭皮改善剤。 The hair growth and scalp improving agent is a hair growth and scalp improving agent for women,
The hair growth and scalp improvement according to any one of claims 1 to 5, further comprising linseed oil, ginger extract, d-α-tocopherol, pueraria mirifica powder, L-methionine and peanut seed coat extract. Agent.
ノコギリヤシ抽出物および米胚芽油をさらに含有することを特徴とする請求項1から5のいずれか1つに記載の育毛および頭皮改善剤。 The hair growth and scalp improving agent is a male hair growth and scalp improving agent,
The hair-growth and scalp improving agent according to any one of claims 1 to 5, further comprising a saw palmetto extract and rice germ oil.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014155105A JP6189803B2 (en) | 2014-07-30 | 2014-07-30 | Orally administered hair growth and scalp improving agents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014155105A JP6189803B2 (en) | 2014-07-30 | 2014-07-30 | Orally administered hair growth and scalp improving agents |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016030748A true JP2016030748A (en) | 2016-03-07 |
JP6189803B2 JP6189803B2 (en) | 2017-08-30 |
Family
ID=55441343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014155105A Active JP6189803B2 (en) | 2014-07-30 | 2014-07-30 | Orally administered hair growth and scalp improving agents |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6189803B2 (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09175982A (en) * | 1995-12-28 | 1997-07-08 | Nikka Uisukii Kk | Cosmetic |
US7211274B2 (en) * | 2002-05-22 | 2007-05-01 | Hovis Sdn Bhd | Hair growth formulation |
JP2008500322A (en) * | 2004-05-26 | 2008-01-10 | ケージーケー シナジャイズ インコーポレイテッド | Pharmaceutical products for the treatment of neoplastic diseases and inflammation |
JP4172864B2 (en) * | 1999-01-12 | 2008-10-29 | 協和醗酵工業株式会社 | Hair restorer and oral hair restorer |
JP2010013429A (en) * | 2008-07-01 | 2010-01-21 | Takashi Suzuki | Scalp preparation for external use |
JP2011105695A (en) * | 2009-11-13 | 2011-06-02 | Bhn Kk | Peroral hair-growth stimulant |
JP2012012354A (en) * | 2010-07-02 | 2012-01-19 | Nippon Barrier Free:Kk | Hair growth promoter |
JP2013234140A (en) * | 2012-05-08 | 2013-11-21 | Oriza Yuka Kk | Trichogenous agent |
-
2014
- 2014-07-30 JP JP2014155105A patent/JP6189803B2/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09175982A (en) * | 1995-12-28 | 1997-07-08 | Nikka Uisukii Kk | Cosmetic |
JP4172864B2 (en) * | 1999-01-12 | 2008-10-29 | 協和醗酵工業株式会社 | Hair restorer and oral hair restorer |
US7211274B2 (en) * | 2002-05-22 | 2007-05-01 | Hovis Sdn Bhd | Hair growth formulation |
JP2008500322A (en) * | 2004-05-26 | 2008-01-10 | ケージーケー シナジャイズ インコーポレイテッド | Pharmaceutical products for the treatment of neoplastic diseases and inflammation |
JP2010013429A (en) * | 2008-07-01 | 2010-01-21 | Takashi Suzuki | Scalp preparation for external use |
JP2011105695A (en) * | 2009-11-13 | 2011-06-02 | Bhn Kk | Peroral hair-growth stimulant |
JP2012012354A (en) * | 2010-07-02 | 2012-01-19 | Nippon Barrier Free:Kk | Hair growth promoter |
JP2013234140A (en) * | 2012-05-08 | 2013-11-21 | Oriza Yuka Kk | Trichogenous agent |
Non-Patent Citations (2)
Title |
---|
TROPICAL LIFE SCIENCES RESEARCH, vol. 21(2), JPN6017021233, 2010, pages 91 - 99, ISSN: 0003580571 * |
プレスリリースゼロ, JPN6017021235, 17 November 2013 (2013-11-17), pages 1 - 3, ISSN: 0003580572 * |
Also Published As
Publication number | Publication date |
---|---|
JP6189803B2 (en) | 2017-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2969179B2 (en) | Synthetic preparations to promote hair growth and, optionally, skin and nail growth, to prevent or control hair loss | |
JP6354107B2 (en) | Edible cricket composition for promoting hair growth, preventing hair loss and improving hair follicles | |
CN109156829A (en) | A kind of Isin glue collagen composition and its preparation method and application | |
JP2010502662A (en) | Skin care composition | |
CN110381971A (en) | Composition is used in the improvement of Menopause symptom | |
JP2021501206A (en) | Nutritional composition containing a source of vegetable fatty acids | |
KR20130088997A (en) | Cosmetic composition for hair growth and restoration from caviar extracts and its fermentation | |
KR101661245B1 (en) | Hair loss preventing, skin and scalp protecting herbal cosmetic composition containing extracts of saxifrage, coptis, houttuynia, ginseng, peony root, paeonia suffruticosa, yeast and pleuropterus multiflorus, and its manufacturing method | |
Charlton | Eating well: ageing gracefully! | |
JP6444583B2 (en) | Oral composition | |
JP6189803B2 (en) | Orally administered hair growth and scalp improving agents | |
AT511776A1 (en) | USE OF CITRULLINE AND A COMBINATION PREPARATION FOR IMPROVING MALE FERTILITY | |
JP2007236308A (en) | Food composition | |
CN102599574A (en) | Aloe/carrot compound beverage with plant aroma | |
CN110381954A (en) | Menopause anesis composition comprising tectorigenin -7-O- xylose glucose glycosides | |
EP3016640A1 (en) | Kit with multiple nutritional supplements and a method for assembling thereof | |
JP2003024010A (en) | Function-enhancing supplementary food comprising as main ingredient green tea catechin | |
US20090098217A1 (en) | Compositions and methods for promoting thicker hair | |
RU2686632C1 (en) | Body weight control composition | |
JP2002360220A (en) | Health supplement food having improving action for interruption in circulation of blood | |
JP2010047529A (en) | Muscular atrophy inhibitor | |
CN105377220A (en) | Combination of petroselinic acid and zinc for oral administration for hair aging control | |
US9918947B2 (en) | Composition of olivetol and method of use to reduce or inhibit the effects of tetrahydrocannabinol in the human body | |
JP6483244B2 (en) | Nourishing tonic containing bee cub | |
CN109674050A (en) | Antifatigue food compositions and antifatigue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170502 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20170502 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20170517 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170607 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170620 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170704 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170801 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170803 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6189803 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |